Fig. 7From: Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapyThe MDSC-targeting therapeutic strategies. Current clinical therapies targeting MDSCs are mainly focused on four aspects: depleting MDSCs, differentiating MDSCs, inhibiting MDSCs immunosuppressive activity, and blocking MDSCs expansion or activationBack to article page